Table of Contents

2023 OCT- Q3 ISSUE
FREE ACCESS: Cytoreductive Nephrectomy for met-RCC – Current Concepts and Contentions in the Era of ICIs
FREE ACCESS: Current Perspective on the Impact of Endogenous Retroviruses in ccRCC
FREE ACCESS: An Opportunity to Study Mechanisms of Palliative Care by Integrating into Management of Treatment of RCC
FREE ACCESS: HIF Pathway Inhibition hold much promise and Point Toward an expanding RCC Armamentarium- Editorial Memo
FREE ACCESS: Journal Club
FREE ACCESS: KCJ Medical Intelligence

2023 MARCH - Q2 ISSUE
FREE ACCESS: Ex-Vivo Partial Nephrectomy in a Solitary Kidney
FREE ACCESS: Robotic-assisted cytoreductive partial nephrectomy for msRCC following IO
FREE ACCESS: Kidney Cancer Updates from the 2023 ASCO Meeting in Chicago
FREE ACCESS: ASCO 2023 - Recommended Abstracts
FREE ACCESS: Journal Club
FREE ACCESS: ASCO 2023 Kidney Cancer Roundup - Editor's Memo

2022 MARCH - Q1 ISSUE
FREE ACCESS: Recent Advances in BEMPEG (NKTR-214) plus NIVOLUMAB Combination Strategies in Advanced Renal Cell Carcinoma
FREE ACCESS: The Latinx Disparity in Surgery for Kidney Cancer: Data from The South Texas Region
FREE ACCESS: Moving Beyond BMI – Developments in Body Composition and Muscle Measurement in RCC
FREE ACCESS: Kidney Cancer Research Highlights from ASCO GU 2022 Meeting
FREE ACCESS: ASCO GU22 – Kidney Cancer Highlights
FREE ACCESS: 20th Anniversary of Kidney Cancer Journal - Editor's Memo

DECEMBER 2021 ISSUE
FREE ACCESS: Radiological Correlates of pT3a Kidney Cancer: Importance of Irregular Tumor Sinus Border
FREE ACCESS: COMMENTARY: How Can We Predict pT3a Kidney Cancer and What Does It Mean?
FREE ACCESS: A Tribute to Dr. Christopher G. Wood, MD
FREE ACCESS: IKCS 2021- TOP ABSTRACTS
FREE ACCESS: IKCS 2021 meeting coverage. Marc Matrana, MD.
FREE ACCESS: The COVID-19 conundrum, vaccines, and cancer care. Robert A. Figlin, MD
FREE ACCESS: KCJ Journal Club

JUNE 2021 ISSUE
FREE ACCESS: Tissue based biomarkers in non-clear cell RCC: Correlative analysis from the ASPEN clinical trial
FREE ACCESS: The Pathway of Belzutifan, from clinical trials to clinical practice:
FREE ACCESS: The Current and Evolving Therapeutic Paradigm in the Management of Metastatic Renal Cell Carcinoma
FREE ACCESS: EXPERT PERSPECTIVES - Nicholas J. Vogelzang, MD, FASCO, FACP
FREE ACCESS: EDITOR'S MEMO
FREE ACCESS: KCJ Journal Club
FREE ACCESS: MEDICAL INTELLIGENCE

JUNE 2021 ISSUE
FREE ACCESS: Resource-efficient pooled sequencing expands translational impact in solid tumors
FREE ACCESS: ROUNDTABLE: Changes, Challenges and Opportunities in Cancer Care During the COVID-19 Era and Beyond
FREE ACCESS: Renal Cell Carcinoma Associated with Germline Mutations in the Krebs Cycle
FREE ACCESS: Editor's Memo - Robert A. Figlin, MD
FREE ACCESS: KCJ Journal Club
FREE ACCESS: Newsworthy, late-breaking information from Web-based sources, professional societies, and government agencies

ASCO SUPPLEMENT - JUNE 2021
FREE ACCESS: RECOMMENDED ABSTRACTS IN KIDNEY CANCER
FREE ACCESS: Practice Changing Results in RCC come from ASCO21
FREE ACCESS: ASCO21 – Kidney Cancer Highlights
FREE ACCESS: ASCO21 – Key Updates for Kidney Cancer Patients
FREE ACCESS: Novel Strategies in Locally Advanced Kidney Cancer – Highlights from KEYNOTE-564

MARCH 2021 ISSUE
FREE ACCESS: ROUNDTABLE: TKIs Beyond Second-Line Therapy: New Perspectives in Renal Cell Carcinoma Therapeutics
FREE ACCESS: Dissecting the role of lymphadenectomy in the management of renal cell carcinoma
FREE ACCESS: It’s Clear as Day: HIF Signaling is Driving Force of the Clear Cell Morphology
FREE ACCESS: Editor's Memo - Robert A. Figlin, MD
FREE ACCESS: Journal Club
Newsworthy, late-breaking information from Web-based sources, professional societies, and government agencies
FREE ACCESS: Editor's Memo - Robert A. Figlin, MD (Recent)

DECEMBER 2020 ISSUE
FREE ACCESS: Impact of Mycobacterial Infections on Outcomes of Patients with Metastatic Renal Cell Carcinoma
FREE ACCESS: Dissecting the role of lymphadenectomy in the management of renal cell carcinoma
FREE ACCESS: HIF-inhibitors in Renal Cell Carcinomas: A Review of Current Trials
FREE ACCESS: Academic Mentorship: Choosing the Right Research Mentor(s)
KCJ EDITOR’S MEMO
KCJ MEDICAL INTELLIGENCE
KCJ JOURNAL CLUB - ESSENTIAL PEER-REVIEWED READING IN KIDNEY CANCER (FREE ACCESS available soon)

KCJ

Vol 19, Issue 2
June 2021

Table of contents

Article Tools

Stay Connected to KCJ